Protein acetylation in metabolism-metabolites and cofactors

Nature Reviews Endocrinology

Volumn 12, Issue 1, 2016, Pages 43-60

  Menzies, Keir J ^a   Zhang, Hongbo ^b   Katsyuba, Elena ^b   Auwerx, Johan ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETYL COENZYME A; ACYLTRANSFERASE; BUTYRIC ACID; COENZYME A; LYSINE ACETYLTRANSFERASE; LYSINE DEACETYLASE; MALONYL COENZYME A; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; UNCLASSIFIED DRUG; ZINC; COENZYME; HISTONE ACETYLTRANSFERASE;

BIOSYNTHESIS; CELLULAR DISTRIBUTION; DEACETYLATION; ENERGY METABOLISM; HUMAN; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN METABOLISM; REVIEW; ACETYLATION; ANIMAL; COENZYME; GENETIC EPIGENESIS; METABOLISM; PHYSIOLOGY; PROTEIN PROCESSING;

3-HYDROXYBUTYRIC ACID; ACETYLATION; ANIMALS; COENZYMES; ENERGY METABOLISM; EPIGENESIS, GENETIC; HISTONE ACETYLTRANSFERASES; HUMANS; NIACINAMIDE; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84949624063     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2015.181     Document Type: Review

References (264)

1. Choudhary, C., Weinert, B. T., Nishida, Y., Verdin, E., & Mann, M. The growing landscape of lysine acetylation links metabolism and cell signalling. Nat. Rev. Mol. Cell Biol. 15, 536-550 (2014
2. Canto, C., Sauve, A. A., & Bai, P. Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Mol. Aspects Med. 34, 1168-1201 (2013
3. Beausoleil, S. A., et al. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc. Natl Acad. Sci. USA 101, 12130-12135 (2004
4. Khoury, G. A., Baliban, R. C., & Floudas, C. A. Proteome-wide post-Translational modification statistics: frequency analysis and curation of the swiss-prot database. Sci. Rep. 1, 90 (2011
5. Starheim, K. K., Gevaert, K., & Arnesen, T. Protein N terminal acetyltransferases: when the start matters. Trends Biochem. Sci. 37, 152-161 (2012
6. Yang, X. J., & Gr?goire, S. Metabolism, cytoskeleton and cellular signalling in the grip of protein N?-And O acetylation. EMBO Rep. 8, 556-562 (2007
7. Kaelin, W. G., & McKnight, S. L. Influence of metabolism on epigenetics and disease. Cell 153, 56-69 (2013
8. Roth, S. Y., Denu, J. M., & Allis, C. D. Histone acetyltransferases. Annu. Rev. Biochem. 70, 81-120 (2001
9. Menzies, K., & Auwerx, J. An acetylation rheostat for the control of muscle energy homeostasis. J. Mol. Endocrinol. 51, T101-T113 (2013
10. Doi, M., Hirayama, J., & Sassone-Corsi, P. Circadian regulator CLOCK is a histone acetyltransferase. Cell 125, 497-508 (2006
11. Ruiz-Carrillo, A., Wangh, L. J., & Allfrey, V. G. Processing of newly synthesized histone molecules. Science 190, 117-128 (1975
12. Haberland, M., Montgomery, R. L., & Olson, E. N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10, 32-42 (2009
13. Carrozza, M. J., Utley, R. T., Workman, J. L., & Cote, J. The diverse functions of histone acetyltransferase complexes. Trends Genet. 19, 321-329 (2003
14. Houtkooper, R. H., Pirinen, E., & Auwerx, J. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13, 225-238 (2012
15. Liu, X., et al. Transcriptional repression by histone deacetylases in plants. Mol. Plant 7, 764-772 (2014
16. Imai, S., Armstrong, C. M., Kaeberlein, M., & Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795-800 (2000
17. Lin, S. J., Defossez, P. A., & Guarente, L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289, 2126-2128 (2000
18. Hall, J. A., Dominy, J. E., Lee, Y., & Puigserver, P. The sirtuin family's role in aging and age-Associated pathologies. J. Clin. Invest. 123, 973-979 (2013
19. Lagouge, M., et al Resveratrol Improves Mitochondrial Function and Protects Against Metabolic Disease by Activating SIRT1 and PGC 1α. Cell 127, 1109-1122 (2006
20. Rodgers, J T., et Al. Nutrient Control of Glucose Homeostasis Through A Complex of PGC 1α and SIRT1. Nature 434, 113-118 (2005
21. Canto, C., et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 11, 213-219 (2010
22. Motta, M. C., et al. Mammalian SIRT1 represses forkhead transcription factors. Cell 116, 551-563 (2004
23. Li, X., et al. SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol. Cell 28, 91-106 (2007
24. Rodgers, J. T., & Puigserver, P. Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Proc. Natl Acad. Sci. USA 104, 12861-12866 (2007
25. Liu, Y., et al. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 456, 269-273 (2008
26. Qiang, L., et al. Brown remodeling of white adipose tissue by SirT1 dependent deacetylation of Pparγ. Cell 150, 620-632 (2012
27. Hallows, W. C., Lee, S., & Denu, J. M. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc. Natl Acad. Sci. USA 103, 10230-10235 (2006
28. Menzies, K. J., Singh, K., Saleem, A., & Hood, D. A. Sirtuin 1 mediated effects of exercise and resveratrol on mitochondrial biogenesis. J. Biol. Chem. 288, 6968-6979 (2013
29. Price, N. L., et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 15, 675-690 (2012
30. Canto, C., et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056-1060 (2009
31. Puigserver, P., et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839 (1998
32. Yoon, J C., et Al. Control of Hepatic Gluconeogenesis Through the Transcriptional Coactivator PGC 1. Nature 413, 131-138 (2001
33. Gerhart-Hines, Z., et al Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC 1α. EMBO J. 26, 1913-1923 (2007
34. Cantó, C., & Auwerx, J. Targeting sirtuin 1 to improve metabolism: all you need is NAD+? Pharmacol. Rev. 64, 166-187 (2012
35. Fernandez-Marcos, P. J., & Auwerx, J. Regulation of PGC 1α, a nodal regulator of mitochondrial biogenesis. Am. J. Clin. Nutr. 93, 884S-890S (2011
36. Dominy, J. E. Jr et al. The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. Mol. Cell 48, 900-913 (2012
37. Zhong, L., et al The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1α. Cell 140, 280-293 (2010
38. Masri, S., et al. Partitioning circadian transcription by SIRT6 leads to segregated control of cellular metabolism. Cell 158, 659-672 (2014
39. Jiang, H., et al. SIRT6 regulates TNF α secretion through hydrolysis of long-chain fatty acyl lysine. Nature 496, 110-113 (2013
40. Feldman, J. L., Baeza, J., & Denu, J. M. Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins. J. Biol. Chem. 288, 31350-31356 (2013
41. Yoshizawa, T., et al. SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway. Cell Metab. 19, 712-721 (2014
42. Ryu, D., et al. A SIRT7 dependent acetylation switch of GABPβ1 controls mitochondrial function. Cell Metab. (2014
43. Shin, J., et al. SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease. Cell Rep. 5, 654-665 (2013
44. Mohrin, M., et al. A mitochondrial UPR-mediated metabolic checkpoint regulates hematopoietic stem cell aging. Science 347, 1374-1377 (2015
45. Vakhrusheva, O., et al. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ. Res. 102, 703-710 (2008
46. Jing, E., Gesta, S., & Kahn, C. R. SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metab. 6, 105-114 (2007
47. Lin, R., et al. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth. Mol. Cell 51, 506-518 (2013
48. Jiang, W., et al. Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase. Mol. Cell 43, 33-44 (2011
49. Bobrowska, A., Donmez, G., Weiss, A., Guarente, L., & Bates, G. SIRT2 ablation has no effect on tubulin acetylation in brain, cholesterol biosynthesis or the progression of Huntington's disease phenotypes in vivo. PLoS ONE 7, e34805 (2012
50. Beirowski, B., et al. Sir two homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par 3/atypical protein kinase C (aPKC) signaling. Proc. Natl Acad. Sci. USA 108, E952-E961 (2011
51. Taes, I., et al. Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS. Hum. Mol. Genet. 22, 1783-1790 (2013
52. Lombard, D. B., et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell Biol. 27, 8807-8814 (2007
53. Hirschey, M. D., et al. SIRT3 regulates mitochondrial fatty-Acid oxidation by reversible enzyme deacetylation. Nature 464, 121-125 (2010
54. Shimazu, T., et al. SIRT3 deacetylates mitochondrial 3 hydroxy 3 methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab. 12, 654-661 (2010
55. Someya, S., et al. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143, 802-812 (2010
56. Ahn, B. H., et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl Acad. Sci. USA 105, 14447-14452 (2008
57. Jing, E., et al. Sirtuin 3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production. Proc. Natl Acad. Sci. USA 108, 14608-14613 (2011
58. Fernandez-Marcos, P. J., et al. Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis. Sci. Rep. 2, 425 (2012
59. Mathias, R. A., et al. Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity. Cell 159, 1615-1625 (2014
60. Haigis, M. C., et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic β cells. Cell 126, 941-954 (2006
61. Argmann, C., & Auwerx, J. Insulin secretion: SIRT4 gets in on the act. Cell 126, 837-839 (2006
62. Laurent, G., et al. SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase. Mol. Cell 50, 686-698 (2013
63. Du, J., et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806-809 (2011
64. Park, J., et al. SIRT5 mediated lysine desuccinylation impacts diverse metabolic pathways. Mol. Cell 50, 919-930 (2013
65. Rardin, M. J., et al. SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab. 18, 920-933 (2013
66. Tan, M., et al Lysine Glutarylation Is A Protein Posttranslational Modification Regulated by SIRT5. Cell Metab. 19, 605-617 (2014
67. Yu, J., et al. Metabolic characterization of a Sirt5 deficient mouse model. Sci. Rep. 3, 2806 (2013
68. Nakagawa, T., Lomb, D. J., Haigis, M. C., & Guarente, L. SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137, 560-570 (2009
69. Canto, C., Menzies, K. J., & Auwerx, J. NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 22, 31-53 (2015
70. Mihaylova, M. M., & Shaw, R. J. Metabolic reprogramming by class I and II histone deacetylases. Trends Endocrinol. Metab. 24, 48-57 (2013
71. Haberland, M., Carrer, M., Mokalled, M. H., Montgomery, R. L., & Olson, E. N. Redundant control of adipogenesis by histone deacetylases 1 and 2. J. Biol. Chem. 285, 14663-14670 (2010
72. Mihaylova, M. M., & Shaw, R. J. Metabolic reprogramming by class I and II histone deacetylases. Trends Endocrinol. Metab. 24, 48-57 (2013
73. Sun, Z., et al. Diet-induced lethality due to deletion of the Hdac3 gene in heart and skeletal muscle. J. Biol. Chem. 286, 33301-33309 (2011
74. Fajas, L., et al. The retinoblastoma-histone deacetylase 3 complex inhibits PPARγ and adipocyte differentiation. Dev. Cell 3, 903-910 (2002
75. Montgomery, R. L., et al. Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice. J. Clin. Invest. 118, 3588-3597 (2008
76. Grégoire, S., et al. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol. Cell. Biol. 27, 1280-1295 (2007
77. Feng, D., et al. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 331, 1315-1319 (2011
78. Sun, Z., et al. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat. Med. 18, 934-942 (2012
79. Knutson, S. K., et al. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J. 27, 1017-1028 (2008
80. Verdin, E., Dequiedt, F., & Kasler, H. G. Class II histone deacetylases: versatile regulators. Trends Genet. 19, 286-293 (2003
81. Potthoff, M. J., et al. Histone deacetylase degradation and MEF2 activation promote the formation of slow-Twitch myofibers. J. Clin. Invest. 117, 2459-2467 (2007
82. Yamamoto, H., et al. NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell 147, 827-839 (2011
83. Jo, Y. S., et al. Phosphorylation of the nuclear receptor co-repressor 1 by protein kinase B (PKB/Akt) switches its co-repressor targets in the liver. Hepatology http://dx.doi.org/10.1002/hep.27907
84. Mihaylova, M. M., et al. Class IIa histone deacetylases are hormone-Activated regulators of FOXO and mammalian glucose homeostasis. Cell 145, 607-621 (2011
85. Winkler, R., et al. Histone deacetylase 6 (HDAC6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis. Diabetes 61, 513-523 (2012
86. Funato, H., Oda, S., Yokofujita, J., Igarashi, H., & Kuroda, M. Fasting and high-fat diet alter histone deacetylase expression in the medial hypothalamus. PLoS ONE 6, e18950 (2011
87. Lundh, M., et al. Lysine deacetylases are produced in pancreatic β cells and are differentially regulated by proinflammatory cytokines. Diabetologia 53, 2569-2578 (2010
88. Lerin, C., et al GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC 1α. Cell Metab. 3, 429-438 (2006
89. Lee, Y., et al. Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression. Nature 510, 547-551 (2014
90. Sakai, M., et al. CITED2 links hormonal signaling to PGC 1α acetylation in the regulation of gluconeogenesis. Nat. Med. 18, 612-617 (2012
91. Coste, A., et al. The genetic ablation of SRC 3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC 1α. Proc. Natl Acad. Sci. USA 105, 17187-17192 (2008
92. Sun, C., et al PCAF improves glucose homeostasis by suppressing the gluconeogenic activity of PGC 1α. Cell Rep. 9, 2250-2262 (2014
93. Ravnskjaer, K., et al. Glucagon regulates gluconeogenesis through KAT2B-And WDR5 mediated epigenetic effects. J. Clin. Invest. 123, 4318-4328 (2013
94. Xu, W., et al. Loss of Gcn5l2 leads to increased apoptosis and mesodermal defects during mouse development. Nat. Genet. 26, 229-232 (2000
95. Wang, L., Tang, Y., Cole, P. A., & Marmorstein, R. Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function. Curr. Opin. Struct. Biol. 18, 741-747 (2008
96. Yamauchi, T., et al. Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice. Nat. Genet. 30, 221-226 (2002
97. Takahashi, N., et al. Overexpression and ribozyme-mediated targeting of transcriptional coactivators CREB-binding protein and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of peroxisome proliferator-Activated receptor γ. J. Biol. Chem. 277, 16906-16912 (2002
98. Zhou, X. Y., et al. Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein. Nat. Med. 10, 633-637 (2004
99. Kemper, J. K., et al. FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab. 10, 392-404 (2009
100. Gelman, L., et al. p300 interacts with the N and C terminal part of PPARγ2 in a ligand-independent and-dependent manner, respectively. J. Biol. Chem. 274, 7681-7688 (1999
101. Bai, P., et al. PARP 1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 13, 461-468 (2011
102. Canto, C., et al. The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 15, 838-847 (2012
103. Alano, C. C., Ying, W., & Swanson, R. A. Poly(ADP-ribose) polymerase 1 mediated cell death in astrocytes requires NAD+ depletion and mitochondrial permeability transition. J. Biol. Chem. 279, 18895-18902 (2004
104. Revollo, J. R., Grimm, A. A., & Imai, S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J. Biol. Chem. 279, 50754-50763 (2004
105. Houtkooper, R. H., Canto, C., Wanders, R. J., & Auwerx, J. The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr. Rev. 31, 194-223 (2010
106. Stein, L. R., & Imai, S. The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol. Metab. 23, 420-428 (2012
107. van Roermund, C. W., Elgersma, Y., Singh, N., Wanders, R. J., & Tabak, H. F. The membrane of peroxisomes in Saccharomyces cerevisiae is impermeable to NAD(H) and acetyl-CoA under in vivo conditions. EMBO J. 14, 3480-3486 (1995
108. Barile, M., Passarella, S., Danese, G., & Quagliariello, E. Rat liver mitochondria can synthesize nicotinamide adenine dinucleotide from nicotinamide mononucleotide and ATP via a putative matrix nicotinamide mononucleotide adenylyltransferase. Biochem. Mol. Biol. Int. 38, 297-306 (1996
109. Berger, F., Lau, C., Dahlmann, M., & Ziegler, M. Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J. Biol. Chem. 280, 36334-36341 (2005
110. Yang, H., et al. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130, 1095-1107 (2007
111. Zhang, T., et al. Regulation of poly(ADP-ribose) polymerase 1 dependent gene expression through promoter-directed recruitment of a nuclear NAD+ synthase. J. Biol. Chem. 287, 12405-12416 (2012
112. Di Lisa, F., Menabo, R., Canton, M., Barile, M., & Bernardi, P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J. Biol. Chem. 276, 2571-2575 (2001
113. Pittelli, M., et al. Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool. J. Biol. Chem. 285, 34106-34114 (2010
114. Alano, C. C., et al. Differences among cell types in NAD+ compartmentalization: a comparison of neurons, astrocytes, and cardiac myocytes. J. Neurosci. Res. 85, 3378-3385 (2007
115. Tischler, M. E., Friedrichs, D., Coll., K., & Williamson, J. R. Pyridine nucleotide distributions and enzyme mass action ratios in hepatocytes from fed and starved rats. Arch. Biochem. Biophys. 184, 222-236 (1977
116. Pittelli, M., et al. Pharmacological effects of exogenous NAD on mitochondrial bioenergetics, DNA repair, and apoptosis. Mol. Pharmacol. 80, 1136-1146 (2011
117. Bogan, K. L., & Brenner, C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu. Rev. Nutr. 28, 115-130 (2008
118. Rongvaux, A., Andris, F., Van Gool, F., & Leo, O. Reconstructing eukaryotic NAD metabolism. Bioessays 25, 683-690 (2003
119. Chi, Y., & Sauve, A. A. Nicotinamide riboside, a trace nutrient in foods, is a vitamin B3 with effects on energy metabolism and neuroprotection. Curr. Opin. Clin. Nutr. Metab. Care 16, 657-661 (2013
120. Bender, D. A. Biochemistry of tryptophan in health and disease. Mol. Aspects Med. 6, 101-197 (1983
121. Rongvaux, A., et al. Pre B cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur. J. Immunol. 32, 3225-3234 (2002
122. Emanuelli, M., et al. Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase. J. Biol. Chem. 276, 406-412 (2001
123. Yalowitz, J. A., et al. Characterization of human brain nicotinamide 5'-mononucleotide adenylyltransferase 2 and expression in human pancreas. Biochem. J. 377, 317-326 (2004
124. Zhang, X., et al. Structural characterization of a human cytosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis. J. Biol. Chem. 278, 13503-13511 (2003
125. Revollo, J. R., et al. Nampt/PBEF/Visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme. Cell Metab. 6, 363-375 (2007
126. Fulco, M., et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev. Cell 14, 661-673 (2008
127. van der Veer, E., et al. Extension of human cell lifespan by nicotinamide phosphoribosyltransferase. J. Biol. Chem. 282, 10841-10845 (2007
128. Rongvaux, A., et al. Nicotinamide phosphoribosyl transferase/pre B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress. J. Immunol. 181, 4685-4695 (2008
129. Lu, S. P., Kato, M., & Lin, S. J. Assimilation of endogenous nicotinamide riboside is essential for calorie restriction-mediated life span extension in Saccharomyces cerevisiae. J. Biol. Chem. 284, 17110-17119 (2009
130. Nikiforov, A., Dolle, C., Niere, M., & Ziegler, M. Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J. Biol. Chem. 286, 21767-21778 (2011
131. Belenky, P., et al Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+. Cell 129, 473-484 (2007
132. Bieganowski, P., & Brenner, C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell 117, 495-502 (2004
133. Mouchiroud, L., et al. The NAD+/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154, 430-441 (2013
134. Sasaki, Y., Araki, T., & Milbrandt, J. Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J. Neurosci. 26, 8484-8491 (2006
135. Khan, N. A., et al. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol. Med. 6, 721-731 (2014
136. Cerutti, R., et al. NAD+-dependent activation of sirt1 corrects the phenotype in a mouse model of mitochondrial disease. Cell Metab. 19, 1042-1049 (2014
137. Kameshita, I., Matsuda, Z., Taniguchi, T., & Shizuta, Y. Poly (ADP-Ribose) synthetase. Separation and identification of three proteolytic fragments as the substrate-binding domain, the DNA-binding domain, and the automodification domain. J. Biol. Chem. 259, 4770-4776 (1984
138. Diani-Moore, S., et al. Identification of the aryl hydrocarbon receptor target gene TiPARP as a mediator of suppression of hepatic gluconeogenesis by 2, 3, 7, 8 tetrachlorodibenzo p-dioxin and of nicotinamide as a corrective agent for this effect. J. Biol. Chem. 285, 38801-38810 (2010
139. Chiang, Y. J., et al. Generation and characterization of telomere length maintenance in tankyrase 2 deficient mice. Mol. Cell. Biol. 26, 2037-2043 (2006
140. Asher, G., et al. Poly(ADP-ribose) polymerase 1 participates in the phase entrainment of circadian clocks to feeding. Cell 142, 943-953 (2010
141. Malavasi, F., et al. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol. Rev. 88, 841-886 (2008
142. Pirinen, E., et al. PharmacologicaliInhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab. 19, 1034-1041 (2014
143. Barbosa, M. T., et al. The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity. FASEB J. 21, 3629-3639 (2007
144. Aksoy, P., et al. Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38. Biochem. Biophys. Res. Commun. 349, 353-359 (2006
145. Aksoy, P., White, T. A., Thompson, M., & Chini, E. N. Regulation of intracellular levels of NAD: a novel role for CD38. Biochem. Biophys. Res. Comm. 345, 1386-1392 (2006
146. Lehmann, M., et al. ARTD1 induced poly ADP ribose formation enhances PPARγ ligand binding and co-factor exchange. Nucleic Acids Res. 43, 129-142 (2015
147. Chen, D., et al. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 22, 1753-1757 (2008
148. Costford, S. R., et al. Skeletal muscle NAMPT is induced by exercise in humans. Am. J. Physiol. Endocrinol. Metab. 298, E117-E126 (2010
149. Williamson, D. H., Lund, P., & Krebs, H. A. The redox state of free nicotinamide-Adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem. J. 103, 514-527 (1967
150. Agrimi, G., et al. Deletion or overexpression of mitochondrial NAD+ carriers in Saccharomyces cerevisiae alters cellular NAD and ATP contents and affects mitochondrial metabolism and the rate of glycolysis. Appl. Environ. Microbiol. 77, 2239-2246 (2011
151. Eckel-Mahan, K., & Sassone-Corsi, P. Metabolism and the circadian clock converge. Physiol. Rev. 93, 107-135 (2013
152. Nakahata, Y., et al. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 134, 329-340 (2008
153. Ramsey, K. M., et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 324, 651-654 (2009
154. Pastore, S., & Hood, D. A. Endurance training ameliorates the metabolic and performance characteristics of circadian Clock mutant mice. J. Appl. Physiol. (1985) 114, 1076-1084 (2013
155. Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M., & Sassone-Corsi, P Circadian Control of the NAD+ Salvage Pathway by CLOCK SIRT1. Science 324, 654-657 (2009
156. Peek, C. B., et al. Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science 342, 1243417 (2013
157. Chang, H. C., & Guarente, L. SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell 153, 1448-1460 (2013
158. Asher, G., et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 134, 317-328 (2008
159. Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., & Sinclair, D. A. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J. Biol. Chem. 277, 45099-45107 (2002
160. Borra, M. T., Langer, M. R., Slama, J. T., & Denu, J. M. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases. Biochemistry 43, 9877-9887 (2004
161. Anderson, R. M., Bitterman, K. J., Wood, J. G., Medvedik, O., & Sinclair, D. A. Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 423, 181-185 (2003
162. Qin, W., et al. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J. Biol. Chem. 281, 21745-21754 (2006
163. Yang, S. J., et al. Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes. J. Nutr. Biochem. 25, 66-72 (2014
164. Kang-Lee, Y. A., et al. Metabolic effects of nicotinamide administration in rats. J. Nutr. 113, 215-221 (1983
165. Yi, C. H., et al. Metabolic regulation of protein N α acetylation by Bcl-xL promotes cell survival. Cell 146, 607-620 (2011
166. Takahashi, H., McCaffery, J. M., Irizarry, R. A., & Boeke, J. D. Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription. Mol. Cell 23, 207-217 (2006
167. Friis, R. M., et al. A glycolytic burst drives glucose induction of global histone acetylation by picNuA4 and SAGA. Nucleic Acids Res. 37, 3969-3980 (2009
168. Wellen, K. E., et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324, 1076-1080 (2009
169. Cai, L., Sutter, B. M., Li, B., & Tu, B. P. Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. Mol. Cell 42, 426-437 (2011
170. Zhang, M., Galdieri, L., & Vancura, A. The yeast AMPK homolog SNF1 regulates acetyl coenzyme A homeostasis and histone acetylation. Mol. Cell Biol. 33, 4701-4717 (2013
171. Wagner, G. R., & Payne, R. M. Widespread and enzyme-independent N?-Acetylation and N?-succinylation of proteins in the chemical conditions of the mitochondrial matrix. J. Biol. Chem. 288, 29036-29045 (2013
172. Weinert, B. T., et al. Acetylation dynamics and stoichiometry in Saccharomyces cerevisiae. Mol. Syst. Biol. 10, 716 (2014
173. Paik, W. K., Pearson, D., Lee, H. W., & Kim, S. Nonenzymatic acetylation of histones with acetyl-CoA. Biochim. Biophys. Acta 213, 513-522 (1970
174. Tanner, K. G., et al. Catalytic mechanism and function of invariant glutamic acid 173 from the histone acetyltransferase GCN5 transcriptional coactivator. J. Biol. Chem. 274, 18157-18160 (1999
175. Talcott, B., & Moore, M. S. Getting across the nuclear pore complex. Trends Cell Biol. 9, 312-318 (1999
176. Wente, S. R., & Rout, M. P. The nuclear pore complex and nuclear transport. Cold Spring Harb. Perspect. Biol. 2, a000562 (2010
177. Hirschey, M. D., et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol. Cell 44, 177-190 (2011
178. Schwer, B., et al. Calorie restriction alters mitochondrial protein acetylation. Aging Cell 8, 604-606 (2009
179. Hebert, A. S., et al. Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol. Cell 49, 186-199 (2013
180. Pougovkina, O., et al. Mitochondrial protein acetylation is driven by acetyl-CoA from fatty acid oxidation. Hum. Mol. Genet. 23, 3513-3522 (2014
181. De Virgilio, C., et al. Cloning and disruption of a gene required for growth on acetate but not on ethanol: the acetyl-coenzyme A synthetase gene of Saccharomyces cerevisiae. Yeast 8, 1043-1051 (1992
182. Kumar, A., et al. Subcellular localization of the yeast proteome. Genes Dev. 16, 707-719 (2002
183. Huh, W. K., et al. Global analysis of protein localization in budding yeast. Nature 425, 686-691 (2003
184. van den Berg, M. A., et al. The two acetyl-coenzyme A synthetases of Saccharomyces cerevisiae differ with respect to kinetic properties and transcriptional regulation. J. Biol. Chem. 271, 28953-28959 (1996
185. Kratzer, S., & Schuller, H. J. Carbon source-dependent regulation of the acetyl-coenzyme A synthetase-encoding gene ACS1 from Saccharomyces cerevisiae. Gene 161, 75-79 (1995
186. Kals, M., Natter, K., Thallinger, G G., Trajanoski, Z., & Kohlwein, S. D. YPL.db2: the Yeast Protein Localization database, version 2.0. Yeast 22, 213-218 (2005
187. Fujino, T., Kondo, J., Ishikawa, M., Morikawa, K., & Yamamoto, T. T. Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate. J. Biol. Chem. 276, 11420-11426 (2001
188. Luong, A., Hannah, V. C., Brown, M. S., & Goldstein, J. L. Molecular characterization of human acetyl-CoA synthetase, an enzyme regulated by sterol regulatory element-binding proteins. J. Biol. Chem. 275, 26458-26466 (2000
189. Ariyannur, P. S., et al. Nuclear-cytoplasmic localization of acetyl coenzyme a synthetase 1 in the rat brain. J. Comp. Neurol. 518, 2952-2977 (2010
190. Schwer, B., Bunkenborg, J., Verdin, R. O., Andersen, J. S., & Verdin, E. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc. Natl Acad. Sci. USA 103, 10224-10229 (2006
191. Starai, V. J., Takahashi, H., Boeke, J. D., & Escalante-Semerena, J. C. Short-chain fatty acid activation by acyl-coenzyme A synthetases requires SIR2 protein function in Salmonella enterica and Saccharomyces cerevisiae. Genetics 163, 545-555 (2003
192. Kaplan, J. H. Molecular biology of carrier proteins. Cell 72, 13-18 (1993
193. Lee, J. V., et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab. 20, 306-319 (2014
194. Shimazu, T., Hirschey, M. D., Huang, J. Y., Ho, L. T. Y., & Verdin, E. Acetate metabolism and aging: an emerging connection. Mech. Ageing Dev. 131, 511-516 (2010
195. Comerford, S. A., et al. Acetate dependence of tumors. Cell 159, 1591-1602 (2014
196. Mashimo, T., et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell 159, 1603-1614 (2014
197. Dyck, J. R., et al. Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism. Biochem. J. 350, 599-608 (2000
198. Sacksteder, K. A., Morrell, J. C., Wanders, R. J., Matalon, R., & Gould, S. J. MCD encodes peroxisomal and cytoplasmic forms of malonyl-CoA decarboxylase and is mutated in malonyl-CoA decarboxylase deficiency. J. Biol. Chem. 274, 24461-24468 (1999
199. Voilley, N., et al. Cloning and expression of rat pancreatic β-cell malonyl-CoA decarboxylase. Biochem. J. 340, 213-217 (1999
200. Young, M. E., et al. Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids. Am. J. Physiol. Endocrinol. Metab. 280, E471-E479 (2001
201. Sakamoto, J., Barr, R. L., Kavanagh, K. M., & Lopaschuk, G. D. Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart. Am. J. Physiol. Heart Circ. Physiol. 278, H1196-H1204(2000
202. Dean, D., et al. Exercise diminishes the activity of acetyl-CoA carboxylase in human muscle. Diabetes 49, 1295-1300 (2000
203. Chow, J. D., et al. Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylation. Mol. Metab. 3, 419-431 (2014
204. Galdieri, L., & Vancura, A. Acetyl-CoA carboxylase regulates global histone acetylation. J. Biol. Chem. 287, 23865-23876 (2012
205. Galdieri, L., Chang, J., Mehrotra, S., & Vancura, A. Yeast phospholipase C is required for normal acetyl-CoA homeostasis and global histone acetylation. J. Biol. Chem. 288, 27986-27998 (2013
206. Lee, T. I., et al. Redundant roles for the TFIID and SAGA complexes in global transcription. Nature 405, 701-704 (2000
207. Hallows, W. C., et al. Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol. Cell 41, 139-149 (2011
208. Kim, S., et al. Hepatic gene expression profiles in a long-Term high-fat diet-induced obesity mouse model. Gene 340, 99-109 (2004
209. Hirschey, M. D., Shimazu, T., Huang, J. Y., Schwer, B., & Verdin, E. SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism. Cold Spring Harb. Symp. Quant. Biol. 76, 267-277 (2011
210. Sutendra, G., et al. A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation. Cell 158, 84-97 (2014
211. Roche, T. E., et al. Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms. Prog. Nucleic Acid Res. Mol. Biol. 70, 33-75 (2001
212. Cooper, R. H., Randle, P. J., & Denton, R. M. Regulation of heart muscle pyruvate dehydrogenase kinase. Biochem. J. 143, 625-641 (1974
213. Jing, E., et al. Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes 62, 3404-3417 (2013
214. Mori, J., et al. ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4. Am. J. Physiol. Heart Circ. Physiol. 304, H1103-H1113 (2013
215. Fan, J., et al. Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex. Mol. Cell 53, 534-548 (2014
216. Berndsen, C. E., Albaugh, B. N., Tan, S., & Denu, J. M. Catalytic mechanism of a MYST family histone acetyltransferase. Biochemistry 46, 623-629 (2007
217. Tanner, K. G., Langer, M. R., Kim, Y., & Denu, J. M. Kinetic mechanism of the histone acetyltransferase GCN5 from yeast. J. Biol. Chem. 275, 22048-22055 (2000
218. Liu, X., et al. The structural basis of protein acetylation by the p300/CBP transcriptional coactivator. Nature 451, 846-850 (2008
219. Albaugh, B. N., Kolonko, E. M., & Denu, J. M. Kinetic mechanism of the Rtt109-Vps75 histone acetyltransferase-chaperone complex. Biochemistry 49, 6375-6385 (2010
220. Gao, L., et al. Simultaneous quantification of malonyl-CoA and several other short-chain acyl-CoAs in animal tissues by ion-pairing reversed-phase HPLC/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 853, 303-313 (2007
221. Zhao, Y., et al. Zinc deprivation mediates alcohol-induced hepatocyte IL 8 analog expression in rodents via an epigenetic mechanism. Am. J. Pathol. 179, 693-702 (2011
222. Kiilerich, S., et al. Zinc depletion in alcoholic liver diseases. Scand. J. Gastroenterol. 15, 363-367 (1980
223. McClain, C. J., Antonow, D. R., Cohen, D. A., & Shedlofsky, S. I. Zinc metabolism in alcoholic liver disease. Alcohol Clin. Exp. Res. 10, 582-589 (1986
224. Wang, L., Zhou, Z., Saari, J. T., & Kang, Y. J. Alcohol-induced myocardial fibrosis in metallothionein-null mice: prevention by zinc supplementation. Am. J. Pathol. 167, 337-344 (2005
225. Zhou, Z., et al. Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am. J. Pathol. 166, 1681-1690 (2005
226. Chakrabarty, S. P., & Balaram, H. Reversible binding of zinc in Plasmodium falciparum Sir2: structure and activity of the apoenzyme. Biochim. Biophys. Acta 1804, 1743-1750 (2010
227. Du, X., et al. Crystal structure and mechanism of catalysis of a pyrazinamidase from Pyrococcus horikoshii. Biochemistry 40, 14166-14172 (2001
228. Sheng, X., & Liu, Y. A QM/MM study of the catalytic mechanism of nicotinamidase. Org. Biomol. Chem. 12, 1265-1277 (2014
229. Nangle, S. N., et al. Molecular assembly of the period-cryptochrome circadian transcriptional repressor complex. eLife 3, e03674 (2014
230. Schmalen, I., et al. Interaction of circadian clock proteins CRY1 and PER2 is modulated by zinc binding and disulfide bond formation. Cell 157, 1203-1215 (2014
231. Freedman, S. J., et al. Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor 1 α. Proc. Natl Acad. Sci. USA 99, 5367-5372 (2002
232. Akhtar, A., & Becker, P. B. The histone H4 acetyltransferase MOF uses a C2HC zinc finger for substrate recognition. EMBO Rep. 2, 113-118 (2001
233. Yang, X. J. The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res. 32, 959-976 (2004
234. Guilloteau, P., et al. From the gut to the peripheral tissues: the multiple effects of butyrate. Nutr. Res. Rev. 23, 366-384 (2010
235. Wolever, T. M., Josse, R. G., Leiter, L. A., & Chiasson, J. L. Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans. Metabolism 46, 805-811 (1997
236. Davie, J. R. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133, 2485S-2493S (2003
237. Boffa, L. C., Vidali, G., Mann, R. S., & Allfrey, V. G. Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J. Biol. Chem. 253, 3364-3366 (1978
238. Sealy, L., & Chalkley, R. The effect of sodium butyrate on histone modification. Cell 14, 115-121 (1978
239. Candido, E. P., Reeves, R., & Davie, J. R. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14, 105-113 (1978
240. Cahill, G. F. Fuel metabolism in starvation. Annu. Rev. Nutr. 26, 1-22 (2006
241. Cahill, G. F., et al. Hormone-fuel interrelationships during fasting. J. Clin. Invest. 45, 1751-1769 (1966
242. Robinson, A. M., & Williamson, D. H. Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol. Rev. 60, 143-187 (1980
243. Shimazu, T., et al. Suppression of oxidative stress by β hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339, 211-214 (2013
244. Scheibye-Knudsen, M., Fang, E. F., Croteau, D. L., & Bohr, V. A. Contribution of defective mitophagy to the neurodegeneration in DNA repair-deficient disorders. Autophagy 10, 1468-1469 (2014
245. Guarente, L. Linking DNA damage, NAD+/SIRT1, and aging. Cell Metab. 20, 706-707 (2014
246. Braidy, N., et al. Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats. PLoS ONE 6, e19194 (2011
247. Gomes, A. P., et al. Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155, 1624-1638 (2013
248. Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S. i. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet-And age-induced diabetes in mice. Cell Metab. 14, 528-536 (2011
249. Massudi, H., et al. Age-Associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS ONE 7, e42357 (2012
250. Mendelsohn, A. R., & Larrick, J. W. Partial reversal of skeletal muscle aging by restoration of normal NAD+ levels. Rejuvenation Res. 17, 62-69 (2014
251. Ramsey, K. M., Mills, K. F., Satoh, A., & Imai, S. i. Age-Associated loss of Sirt1 mediated enhancement of glucose-stimulated insulin secretion in β cell-specific Sirt1 overexpressing (BESTO) mice. Aging Cell 7, 78-88 (2008
252. Kraus, D., et al. Nicotinamide N methyltransferase knockdown protects against diet-induced obesity. Nature 508, 258-262 (2014
253. van de Weijer, T., et al. Evidence for a direct effect of the NAD+ precursor Acipimox on muscle mitochondrial function in humans. Diabetes 64, 1193-1201 (2014
254. Araki, T., Sasaki, Y., & Milbrandt, J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305, 1010-1013 (2004
255. Gong, B., et al. Nicotinamide riboside restores cognition through an upregulation of proliferator-Activated receptor γ coactivator 1α regulated β secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models. Neurobiol. Aging 34, 1581-1588 (2013
256. Benavente, C. A., Schnell, S. A., & Jacobson, E. L. Effects of niacin restriction on sirtuin and PARP responses to photodamage in human skin. PLoS ONE 7, e42276 (2012
257. Tummala, K. S., et al. Inhibition of de novo NAD+ synthesis by oncogenic URI causes liver tumorigenesis through DNA damage. Cancer Cell 26, 826-839 (2014
258. Mukhopadhyay, P., et al. Poly (ADP-ribose) polymerase 1 is a key mediator of liver inflammation and fibrosis. Hepatology 59, 1998-2009 (2014
259. Escande, C., et al. Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes 62, 1084-1093 (2013
260. Jayawardena, R., et al. Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-Analysis.Diabetol. Metab. Syndr. 4, 13 (2012
261. Dawson, A. G. Oxidation of cytosolic NADH formed during aerobic metabolism in mammalian cells. Trends Biochem. Sci. 4, 171-176
262. Baeza, J., Smallegan, M. J., & Denu, J. M. Site-specific reactivity of nonenzymatic lysine acetylation. ACS Chem. Biol. 10, 122-128 (2015
263. Olia, A. S., et al. Nonenzymatic protein acetylation detected by NAPPA protein arrays. ACS Chem. Biol. 10, 2034-2047 (2015
264. Weinert, B. T., et al. Acetyl-phosphate is a critical determinant of lysine acetylation in E. coli. Mol. Cell 51, 265-272 (2013